Cancer detection device proves effective in Uganda
The Tiny Isothermal Nucleic acid quantification sYstem (TINY) has shown promise as a point-ofcare detector of Kaposi sarcoma-associated herpesvirus (KSHV) in resource-limited settings such as subSaharan Africa.
Developed by a team of researchers at Cornell Engineering and Weill Cornell Medicine, US, TINY met its goals in the first round of funding from the National Institutes of Health.
The team is planning expanded testing over the next several years. Future work on TINY will include expanding testing to more locations in Africa, South America and the US, and developing a commercialization plan. The group has applied for patent protection through Cornell’s
Center for Technology Licensing.